TY - JOUR
T1 - Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America
AU - Mata, Ignacio F.
AU - Wilhoite, Greggory J.
AU - Yearout, Dora
AU - Bacon, Justin A.
AU - Cornejo-Olivas, Mario
AU - Mazzetti, Pilar
AU - Marca, Victoria
AU - Ortega, Olimpio
AU - Acosta, Oscar
AU - Cosentino, Carlos
AU - Torres, Luis
AU - Medina, Angel C.
AU - Perez-Pastene, Carolina
AU - Díaz-Grez, Fernando
AU - Vilariño-Güell, Carles
AU - Venegas, Pablo
AU - Miranda, Marcelo
AU - Trujillo-Godoy, Osvaldo
AU - Layson, Luis
AU - Avello, Rodrigo
AU - Dieguez, Elena
AU - Raggio, Victor
AU - Micheli, Federico
AU - Perandones, Claudia
AU - Alvarez, Victoria
AU - Segura-Aguilar, Juan
AU - Farrer, Matthew J.
AU - Zabetian, Cyrus P.
AU - Ross, Owen A.
N1 - Funding Information:
This work was supported by the National Institutes of Health ( R01 NS065070 , P50 NS062684 , P50 NS072187 ), Department of Veterans Affairs ( 1I01BX000531 ), FONDECYT (# 1061083 ), Parkinson’s Disease Foundation , Michael J. Fox Foundation , and the family of Carl and Susan Bolch . Dr Cornejo-Olivas is the recipient of an NIH Fogarty International Clinical Research Fellowship at Vanderbilt University (R24 TW007988).
PY - 2011/9
Y1 - 2011/9
N2 - Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease, with frequencies displaying a high degree of population-specificity. Although more than 100 coding substitutions have been identified, only seven have been proven to be highly penetrant pathogenic mutations. Studies however are lacking in non-white populations. Recently, Lrrk2 p.Q1111H (rs78365431) was identified in two affected Hispanic brothers and absent in 386 non-Hispanic white healthy controls. We therefore screened this variant in 1460 individuals (1150 PD patients and 310 healthy controls) from 4 Latin American countries (Peru, Chile, Uruguay and Argentina).In our case-control series from Peru and Chile we observed an increased frequency of Lrrk2 p.Q1111H in patients (7.9%) compared to controls (5.4%) although the difference did not reach significance (OR 1.38; p = 0.10).In addition, the frequency of Lrrk2 p.Q1111H varied greatly between populations and further screening in a set of pure Amerindian and pure Spanish controls suggested that this variant likely originated in an Amerindian population. Further studies in other Latin American populations are warranted to assess its role as a risk factor for Parkinson's disease. Screening in Parkinson's disease patients from under-represented populations will increase our understanding of the role of LRRK2 variants in disease risk worldwide.
AB - Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease, with frequencies displaying a high degree of population-specificity. Although more than 100 coding substitutions have been identified, only seven have been proven to be highly penetrant pathogenic mutations. Studies however are lacking in non-white populations. Recently, Lrrk2 p.Q1111H (rs78365431) was identified in two affected Hispanic brothers and absent in 386 non-Hispanic white healthy controls. We therefore screened this variant in 1460 individuals (1150 PD patients and 310 healthy controls) from 4 Latin American countries (Peru, Chile, Uruguay and Argentina).In our case-control series from Peru and Chile we observed an increased frequency of Lrrk2 p.Q1111H in patients (7.9%) compared to controls (5.4%) although the difference did not reach significance (OR 1.38; p = 0.10).In addition, the frequency of Lrrk2 p.Q1111H varied greatly between populations and further screening in a set of pure Amerindian and pure Spanish controls suggested that this variant likely originated in an Amerindian population. Further studies in other Latin American populations are warranted to assess its role as a risk factor for Parkinson's disease. Screening in Parkinson's disease patients from under-represented populations will increase our understanding of the role of LRRK2 variants in disease risk worldwide.
KW - Latin America
KW - Lrrk2
KW - Parkinson disease
UR - http://www.scopus.com/inward/record.url?scp=80052366563&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2011.05.003
DO - 10.1016/j.parkreldis.2011.05.003
M3 - Artículo
C2 - 21632271
AN - SCOPUS:80052366563
SN - 1353-8020
VL - 17
SP - 629
EP - 631
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
IS - 8
ER -